» Articles » PMID: 38529481

Osteocyte-mediated Mechanical Response Controls Osteoblast Differentiation and Function

Overview
Journal Front Physiol
Date 2024 Mar 26
PMID 38529481
Authors
Affiliations
Soon will be listed here.
Abstract

Low bone mass is a pervasive global health concern, with implications for osteoporosis, frailty, disability, and mortality. Lifestyle factors, including sedentary habits, metabolic dysfunction, and an aging population, contribute to the escalating prevalence of osteopenia and osteoporosis. The application of mechanical load to bone through physical activity and exercise prevents bone loss, while sufficient mechanical load stimulates new bone mass acquisition. Osteocytes, cells embedded within the bone, receive mechanical signals and translate these mechanical cues into biological signals, termed mechano-transduction. Mechano-transduction signals regulate other bone resident cells, such as osteoblasts and osteoclasts, to orchestrate changes in bone mass. This review explores the mechanisms through which osteocyte-mediated response to mechanical loading regulates osteoblast differentiation and bone formation. An overview of bone cell biology and the impact of mechanical load will be provided, with emphasis on the mechanical cues, mechano-transduction pathways, and factors that direct progenitor cells toward the osteoblast lineage. While there are a wide range of clinically available treatments for osteoporosis, the majority act through manipulation of the osteoclast and may have significant disadvantages. Despite the central role of osteoblasts to the deposition of new bone, few therapies directly target osteoblasts for the preservation of bone mass. Improved understanding of the mechanisms leading to osteoblastogenesis may reveal novel targets for translational investigation.

Citing Articles

Biochemical Mechanisms and Rehabilitation Strategies in Osteoporosis-Related Pain: A Systematic Review.

Iaconisi G, Mancini R, Ricci V, Donati D, Sconza C, Marvulli R Clin Pract. 2024; 14(6):2737-2758.

PMID: 39727804 PMC: 11674043. DOI: 10.3390/clinpract14060216.


Bone Loss in Diabetes Mellitus: Diaporosis.

Kupai K, Kang H, Posa A, Csonka A, Varkonyi T, Valkusz Z Int J Mol Sci. 2024; 25(13).

PMID: 39000376 PMC: 11242219. DOI: 10.3390/ijms25137269.

References
1.
Burra S, Nicolella D, Jiang J . Dark horse in osteocyte biology: Glycocalyx around the dendrites is critical for osteocyte mechanosensing. Commun Integr Biol. 2011; 4(1):48-50. PMC: 3073269. DOI: 10.4161/cib.4.1.13646. View

2.
Shahar R, Dean M . The enigmas of bone without osteocytes. Bonekey Rep. 2014; 2:343. PMC: 3692265. DOI: 10.1038/bonekey.2013.77. View

3.
Li M, Xu D . Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site. Proc Natl Acad Sci U S A. 2020; 117(29):17187-17194. PMC: 7382260. DOI: 10.1073/pnas.2005859117. View

4.
Zhang T, Lin S, Shao X, Zhang Q, Xue C, Zhang S . Effect of matrix stiffness on osteoblast functionalization. Cell Prolif. 2017; 50(3). PMC: 6529113. DOI: 10.1111/cpr.12338. View

5.
Ke H, Richards W, Li X, Ominsky M . Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev. 2012; 33(5):747-83. DOI: 10.1210/er.2011-1060. View